David Caraway is the Chief Medical Officer at Nevro. Nevro, is a global, growth stage medical device company focused on developing innovative, evidence based solutions for the treatment of chronic medical conditions.

Dr. Caraway directs and supports the design, development, and adoption of cutting-edge therapies to advance the field of neuromodulation. He also directs Nevro’s medical affairs function with responsibility for generating and providing medical and scientific information on Nevro’s products.

Dr. Caraway maintained an active clinical and research practice for over 20 years and held leadership positions in the North American Neuromodulation Society and the American Society of Interventional Pain Physicians. Dr. Caraway served as a consultant to numerous companies to further innovation, educate physicians and develop research initiatives. As a nationally recognized expert in neuromodulation, he has published extensively and lectures regionally, nationally and internationally.